A Pilot Study of Telehealth Treatment for Opioid Use Disorders
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 33
- 试验地点
- 2
- 主要终点
- Attendance for MOUD
研究概览
简要总结
This study aims to use an Opioid Use Disorder (OUD) Telehealth Platform to reduce overdose events. This telehealth platform will be pilot tested to evaluate its preliminary efficacy in terms of motivating engagement in medications for OUD (MOUD), as well as its feasibility, acceptability and satisfaction to both first responders/providers and participants.
详细描述
The primary objective of the study is to assess effects of enrollment in a comprehensive telehealth platform, in adults with moderate or severe opioid use disorder with a history of at least one opioid overdose. Adults with moderate or severe opioid use disorder with a history of at least one opioid overdose will be enrolled and the primary endpoint will be attendance at first appointment for medication for opioid use disorder at 30 days.
Secondary aims include assessing engagement in the first MOUD appointment at 90 days and self-report of the number of subsequent overdose events at 30 and 90 days. Exploratory aims include feasibility of intervention, readiness and intention to engage in treatment, acceptability and satisfaction of intervention, and comparison of MOUD engagement with data from previous in-person studies.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Can speak, read and write in English
- •Provision of signed and dated informed consent form
- •Have a history of at least one opioid overdose
- •Screened positive for OUD, moderate or severe, based on the Diagnostic and Statistical Manual-5th Edition
- •Have a working cell phone number and working device that can access a web browser and receive texts (i.e., smartphone, tablet or computer) OR be willing to use a device provided by the study team
- •Can provide a working email address OR be willing to create one
排除标准
- •Current use of buprenorphine, methadone, or naltrexone for a substance use disorder
- •Pregnancy
- •Known current suicide risk based on participant self-report
- •On parole or incarcerated at time of enrollment based on participant self-report
结局指标
主要结局
Attendance for MOUD
时间窗: Up to 30 Days
Overall attendance will be measured by attendance (yes or no) at the first buprenorphine appointment within 30 days of referral.
次要结局
- Overdose Events at 90 Days(Up to 90 days)
- Engagement with MOUD(Up to 90 days)
- Overdose Events at 30 Days(Up to 30 days)